Issue : 01 DOI :
INTERNATIONAL
JOURNAL
OF
DIAGNOSTICS
AND
RESEARCH
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
1
Abstract
This case report explores the integration of Ayurvedic medicine in the management of a 24-year-old male
diagnosed with chronic kidney disease (CKD), referred to as Vrikka Roga in Ayurveda. The patient
presented with severe symptoms including shortness of breath, general weakness, nausea, pruritus, frothy
micturition and an overall loss of vitality. Conventional treatment options such as haemodialysis and
medication had been proposed but were delayed at the patient's discretion. In response, an alternative
therapeutic strategy was implemented, comprising a series of tailored Ayurvedic treatments.
Complementing the Panchkarma therapies, Ayurvedic treatment, lifestyle modifications and Ayurvedic
diet were advised to enhance overall renal health and mitigate CKD symptoms. Preliminary outcomes
post-treatment showed improvement in both subjective symptoms and objective measures of renal
function, suggesting potential benefits of this integrative approach. This report underscores the need for
further rigorous scientific studies to validate the efficacy of Ayurvedic practices in managing CKD and
highlights the potential of Ayurvedic medicine as a complement to conventional nephrology. This case
encourages the exploration of holistic, individualized patient care strategies that address both the
symptoms and underlying etiological factors contributing to kidney diseases.
Keywords: Vrikka Roga, CKD, Ayurveda Treatment, Panchkarma, Proteinuria
P
ISSN No. : 2584-2757
Volume : 02
Issue : 04
Publisher
ROGANIDAN VIKRUTIVIGYAN PG ASSOCIATION
FOR PATHOLOGY AND RADIODIGNOSIS
DOI
: 1 0 . 5 2 8 1 / z e n o d o . 1 6 0 29464
Reg. No. : MAHA-703/16(NAG)
Year of Establishment – 2016
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH
Corresponding author: Dr. Gitika Chaudhary
Article Info: Published on : 15/07/2025
Impact Factor : 1.013
Effective Management of Chronic Kidney Disease (Vrikka Roga) Using
Ayurvedic Treatment : A Case Report
Acharya Manish Ji
1
, Dr. Gitika Chaudhary
2
, Dr. Richa
3
, Dr. Suyash Pratap Singh
4
, Dr. Manjeet Singh
5
, Dr. Pooja
6
1
Director, Meditation Guru, Jeena Sikho Lifecare Limited.
2
Senior Consultant, General Surgeon, BAMS, PGDIP, PGDGS, MS (Ay.), Jeena Sikho lifecare Limited.
3
Research officer, BAMS, PGDIP, CICR, CAIM,CMW, Jeena Sikho lifecare Limited Hospital, Derabassi.
4
Medical Superintendent, BAMS, PGDIP, DNYT, CCMC, Jeena Sikho Lifecare Limited Hospital, Derabassi.
5
Consultant, BAMS, PGDIP, ACLS, CCDN, CAIM, Jeena Sikho Lifecare Limited Hospital, Derabassi.
6
Consultant, BAMS, PGDIP, DAGO, Jeena Sikho Lifecare Limited Hospital, Derabassi.
Cite this article as: - Dr. Gitika Chaudhary (2025) ; Effective Management of Chronic Kidney Disease (Vrikka Roga) Using
Ayurvedic Treatment : A Case Report ;Inter.J.Dignostics and Research 2 (4) 1- 13, DOI : 1 0 . 5 2 8 1 / z e n o d o . 1 6 0 29464
G
A
R
V
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
2
Introduction :
Chronic Kidney Disease (CKD) is defined as a
gradual deterioration of kidney function over a span
of months or years, with each advancing stage
signifying a more severe loss of the kidney's ability
to detoxify the blood. This degradation results in an
accumulation of waste products within the
bloodstream
[1]
. An acute exacerbation of CKD
refers to a sudden and often rapid decline in kidney
function, typically triggered by factors such as
infections, dehydration or exposure to nephrotoxic
substances
[2]
. Managing these acute episodes is
challenging and may require hospitalization and
intensive care due to the complexity of the
condition
[3]
. Conventional management strategies
for CKD focus on addressing underlying causes
such as hypertension and diabetes. These strategies
include stringent dietary management, the use of
renal replacement therapies like dialysis, and in
severe cases, organ transplantation
[4]
. Despite these
advancements, the rising prevalence of CKD
necessitates exploration into additional therapeutic
options. From an Ayurvedic perspective, renal
health is significantly influenced by the balance of
the body’s doshas (fundamental bio elements), with
kidney diseases frequently attributed to
disturbances in ‘Apana Vata’—a subtype of Vata
dosha responsible for elimination processes—and
‘Kapha Dosha,’ which governs fluid balance and
structural stability
[5]
. Ayurvedic texts recommend a
variety of herbs such as Punarnava (Boerhavia
diffusa), Gokshura (Tribulus terrestris) and Varun
(Crataeva nurvala), acknowledged for their renal
protective and regenerative potentials. These herbs
are believed to enhance kidney function through
mechanisms like enhanced diuresis, improved renal
blood flow and nephroprotective effects
[6]
. From
the ayurveda point of view this disease can be co-
related with Vrikka Roga.
Despite the increasing exploration into these
Ayurvedic treatments, there remains a considerable
gap in comprehensive clinical validations which
limits the integration of these traditional remedies
into mainstream medical practice
[7]
. As the global
burden of chronic kidney disease continues to
escalate, it becomes imperative to bridge the gap
between traditional Ayurvedic practices and
contemporary nephrology. This integration could
potentially pave the way for alternate management
strategies that address both the chronic progression
and acute exacerbations of kidney disease, ensuring
these approaches are substantiated by robust
scientific evidence to guarantee efficacy and
safety
[8]
.
Case Presentation:
1. A 24-year-old male patient visited Jeena
Sikho lifecare Limited Hospital, Derabassi,
with an established diagnosis of Chronic
Kidney Disease (CKD) since August 2024.
During the current evaluation, he reported
several troubling symptoms including
shortness of breath upon exertion, mild
fatigue, generalized weakness, nausea,
pruritus, lower backache and an increase in
body weight. Despite medical advice to
initiate haemodialysis owing to worsening
renal function, the patient opted to delay
this treatment. Notably, his clinical
assessment also highlighted frothy
micturition, suggestive of proteinuria.
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
3
A regimen of Ayurvedic medicines and
Panchkarma treatment was formulated along with
conventional renal therapy. The treatment approach
was aimed at rebalancing the body’s bio elements,
specifically targeting improvements in kidney
function and overall symptomatology. This case
underscores the potential utility of integrating
Ayurvedic medicine into the management of
symptoms of Chronic Kidney Disease, particularly
for patients seeking alternatives to conventional
therapies. The patient is taking allopathy treatment
which include Darbepoetin (4k once daily for 14
days), a synthetic hormone for treating anaemia;
Sodium Bicarbonate (1 tablet TID), used to
neutralize stomach acid; Calcium Acetate (1 tablet
BID), which reduces phosphate levels in patients
with kidney disease.
Samprapti of Chronic Kidney Disease (Vrikka
Vikara):
In Ayurveda, the Samprapti (pathogenesis) of
chronic kidney disease or Vrikka Vikara involves a
complex interplay of the Doshas, primarily Vata
and Kapha, and the buildup of Ama (toxins).
Initially, factors such as poor nutrition diet,
sedentary lifestyle, aggravate Vata and Kapha
Doshas. This aggravation leads to the formation
and accumulation of Ama, which then circulates
throughout the body and eventually lodges in the
Vrikka (kidneys), causing obstruction and
impairment in the Mutravaha Srotas.
This blockage hinders the filtration process, leading
to the accumulation of waste products and further
increasing Ama, which exacerbates the condition.
As the kidneys' ability to filter blood diminishes,
symptoms such as hazy urine, weakness, and
nausea manifest. The disruption in the balance of
the three doshas – Vata, Pitta, and Kapha, along
with the continued presence of Ama and
progressive damage to the Vrikka, contributes to the
chronicity and severity of the disease.
Table No. 1:. Vital Parameters
Sr. No
Examination
Findings
1.
Blood Pressure
132/80 mm of Hg
2.
Pulse
90 / min
3.
Weight
71 kg
4.
Height
5 feet 5 inches
Ayurvedic Examination
Table No. 2. : Ashtavidha Pariksha (Eight-fold
Examination)
Sr. No
Examination
Findings
1.
Nadi (Pulse
Vata-Kaphaj
2.
Mutra (Urine)
Safena
3.
Mala (Stool)
Abadha
4.
Jihva (Tongue)
Saam
5.
Shabda (Voice)
Spashta
6.
Sparsha (Touch)
Anushnasheeta
7.
Drik (Eyes)
Avikrita
8.
Akriti
(Appearance)
Avikrita
Underlying Factors (Poor nutrition diet,
sedentary lifestyle)
↓
Aggravation of Kapha and Vata
↓
Formation of Ama
↓
Ama circulates and lodges in the Vrikka
(Kidneys)
↓
Blockage in the Mutravaha Srotas
↓
Impaired Filtration and Accumulation of Waste
↓
Symptoms (Hazy Urine, Weakness, Nausea)
↓
Chronic Kidney Disease (CKD)
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
4
Table No. 3. : Dashavidha Pariksha (Ten-fold
Examination)
Sr. No
Examination
Findings
1.
Prakriti
(Constitution):
Pitta Kapha
2.
Vikriti
(Imbalance):
Vata kaphaj
3.
Sara (Tissue
Excellence):
Madhyam
4.
Samhanana (Body
Build):
Moderate
5.
Pramana (Body
Proportions):
Within normal
limits.
6.
Satmya
(Adaptability):
Avara
7.
Satva
(Psychological
Strength):
Avara
8.
Ahara Shakti
(Digestive
Strength):
Avara
9.
Vyayama Shakti
(Exercise
Capacity):
Madhyam
10.
Vaya (Age):
24yr old
Diagnostic Assessment :
Table 6,7. Laboratory Results:
a. CBC, Renal Function Test, Sr. Electrolyte,
Lipid Profile.
b. Imaging Results: - DTPA Scan done on
04/09/2024
Treatment Plan :
I. Ayurvedic Diet Plan:
[9]
The dietary guidelines
provided by Jeena Sikho Lifecare Limited Hospital
include the following key recommendations:
a. Foods to be avoided:
● Do not consume wheat, refined food, milk
and milk products, coffee and tea and
packed food.
● Avoid eating after 8 PM.
● During solid consume as small bite and
chew 32 times.
b. Hydration:
● During water intake, take sip by sip and
drink slowly to ensure the amount of water
intake each time.
● Drink about 1 liter of alkaline water 3 to 4
times throughout the day.
● Include herbal tea, living water, and
turmeric-infused water as part of your daily
routine.
● Boil 2 liters of water & reduce up to 1 liter
and consume.
c. Millet Intake:
(Charaka Samhita, Sutrasthana 27/88).
[10]
● Incorporate five types of millet into your
diet: Foxtail (Setaria italica), Barnyard
(Echinochloa esculenta), Little (Panicum
sumatrense), Kodo (Paspalum
scrobiculatum) and Browntop (Urochloa
ramose).
● Use only steel cookware for preparing the
millets
● Cook the millets only using mustard oil.
d. Meal Timing and Meal Structure:
1. Early Morning (5:45 AM): Herbal tea,
curry leaves (1 leaf-1 min/5 leaves-5
min) along with raw ginger and
turmeric.
2. Breakfast (9:00-10:00 AM): The patient
had given steamed fruits (Seasonal),
mugda yusha, and a fermented millet
shake (4-5 types).
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
5
3. Morning Snacks (11:00AM): The
patient had given Red juice (150 ml)
and soaked almonds.
4. Lunch (12:30 PM - 2:00 PM): The
patient had received Plate 1 and Plate 2.
Plate 1 had included a steamed salad,
while Plate 2 with cooked millet-based
dish.
5. Evening Snacks (4:00 – 4:20 PM):
Green juice (100-150 ml) along with 4-5
almonds.
6. Dinner (6:15-7:30 PM): The patient had
served a steamed salad, chutney and
soup, as Plate 1, along with millet
khichdi as Plate 2.
e. Fasting:
● It is advised to observe one-day fasting.
f. Special Instructions:
● Express gratitude to the divine before
consuming food or drinks.
● Sit in Vajrasana (a yoga posture) after each
meal.
● 10 minutes slow walk after every meal.
g. Diet Types:
● The diet comprises salt-less solid, semi-
solid and smoothie options.
● Suggested foods included Herbal tea, red
juice, green juice, a variety of steamed
fruits, fermented millet shakes, soaked
almonds and steamed salads.
II. Lifestyle Recommendations were :
(i) Include meditation for relaxation.
(ii) Practice barefoot brisk walk for 30 minutes.
(iii) Ensure 6-8 hours of quality sleep each
night.
(iv) Adhere to a structured daily routine.
Panchkarma Therapies: -
Following a comprehensive evaluation, the patient
was advised to undergo inpatient department (IPD)
treatment for a duration of 5 days. This
recommendation was made to closely monitor his
condition and administer intensive care, aimed at
stabilizing his symptoms and preventing further
deterioration of kidney function. This approach also
allowed for a structured administration of the
Ayurvedic treatment regimen and ensuring
adherence, while providing continuous medical
supervision. The patient was admitted on
03/09/2024 and was discharged on 07/09/2024, the
following interventions were followed during the
admission period.
1. Matra Basti with Guduchyadi Ksheer Basti
(amount – 90ml) :
Matra Basti is a form of Ayurvedic enema, using
medicated oils or ghees. In this case, Guduchyadi
Ksheer Basti involves the use of a medicated
decoction made with Guduchi (Tinospora
cordifolia) and other herbs mixed with milk. The
enema primarily works on the Vata Dosha, which,
according to Ayurveda, governs the body's
excretory functions, including those of the
kidneys. It is soothing, lubricating and can help in
reducing inflammation and promoting the healing
of the urinary tract and kidneys. It is especially
beneficial for restoring and balancing the Apana
Vata, enhancing the body’s natural detoxification
processes and aiding in the management of kidney
disease-related symptoms.
2. Abhyangam with Ksheerbala Oil :
Abhyangam is a traditional Ayurvedic oil massage
that rejuvenates the body, improves circulation,
and helps in detoxification, which is crucial for
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
6
patients with kidney issues. Ksheerbala oil, which
is commonly used during Abhyangam, is prepared
from Bala (Sida cordifolia) infused in milk and
sesame oil. This treatment is known for its anti-
inflammatory and analgesic properties, aiding in
reducing pain and discomfort associated with
kidney disease. Moreover, it helps in calming the
nerves and reducing stress, which can indirectly
benefit kidney function.
3. Avgaha Swedanam for 2 hrs below Navel
region :
Avgaha Swedanam is a sweating therapy that
involves sitting in a tub of medicated ayurvedic
formulations that specifically targets the lower
abdomen below the naval region. This therapy is
beneficial for directly impacting the organs
located in the lower abdomen, including the
kidneys and urinary bladder. The steam and heat
help in dilating blood vessels, improving
circulation to these organs and facilitating the
removal of toxins through induced sweating.
Improved circulation and detoxification support
better kidney function and can help to alleviate
symptoms of CKD.
4. Shiropichu with Dhanvantaram Oil :
Shiropichu is an panchakarma therapy where a
cotton pad soaked in medicated oil is placed on
the head of the patient. Using Dhanvantaram oil,
which is a classic Ayurvedic oil known for its
rejuvenative and calming properties. This
treatment is beneficial for relieving stress and
tension, which are often heightened in chronic
conditions like kidney disease. By soothing the
central nervous system, it helps to manage
systemic stress which can exacerbate health
conditions and impact kidney health negatively.
Medicines Used: - Following medicinal Treatment
was given to the patient during the admission
period.
Table No.4. : Day 1 – 03/09/24
Medications
Sanjeevani Vati
Ingredients of
the formulation
are
Bilva (Aegle marmelos), Sonth
(Zingiber officinale), Pippali
(Piper longum), Haritaki
(Terminalia chebula), Vibhitaki
(Terminalia bellirica), Amalaki
(Phyllanthus emblica), Vacha
(Acorus calamus), Guduchi
(Tinospora cordifolia), and
Bhallataka (Semecarpus
anacardium).
Dose
2 Tablets BD
Anupana
Lukewarm Water (Koshna Jala)
Duration
Adhobhakta (After Meal)
Medications
URI Plus
Ingredients of
the formulation
are
Amalki (Phyllanthus emblica),
Bibhitika (Terminalia bellirica),
Haritiki (Terminalia chebula),
Gokshura (Tribulus terrestris),
Shodhit Guggul (Commiphora
wightii), Guduchi (Tinospora
cordifolia)
Dose
2 Tablets BD
Anupana
Lukewarm Water (Koshna Jala)
Duration
Adhobhakta (After Meal)
Medications
Chitrakadi Vati
Ingredients of
the formulation
are
Chitrak (Plumbago zeylanica),
Pippali (Piper longum), Yava
Kshar (Hordeum vulgare),
Swarjika Kshara, Saindhava
Lavana (Rock salt), Sauvarchala
Lavana (Black salt), Vida
Lavana (a type of salt),
Samudra Lavana (Sea salt),
Audbhida Lavana, Sonth
(Zingiber officinale), Maricha
(Piper nigrum), and Hing (Ferula
asafoetida).
Dose
2 Tablets BD
Anupana
Lukewarm Water (Koshna Jala)
Duration
Pragbhakta (Before Meal)
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
7
Medications
Renotivate Syrup
Ingredients of
the formulation
are
Punarnava (Boerhaavia diffusa),
Gokshura (Tribulus terrestris),
Varun (Crataeva nurvala),
Kasani (Cichorium intybus),
Palaash (Butea monosperma),
and Pasankusha (Euphorbia
tithymaloides).
Dose
20 ml BD
Anupana
Lukewarm Water (Koshna Jala)
Duration
Adhobhakta (After Meal)
Medications
Chander Vati
Ingredients of
the formulation
are
are Kapoor Kachri (Hedychium
spicatum), Vach (Acorus calamus),
Motha (Cyperus rotundus),
Kalmegh (Andrographis
paniculata), Giloy (Tinospora
cordifolia), Devdaru (Cedrus
deodara), Desi Haldi (Curcuma
longa), Atees (Aconitum
heterophyllum), Daru Haldi
(Berberis aristata), and Pipla Mool
(Piper longum root). It also features
detoxifying agents like Chitraka
(Plumbago zeylanica), digestive aids
like Dhaniya (Coriandrum sativum),
and rejuvenators like Harad
(Terminalia chebula), Bahera
(Terminalia bellirica), and Amla
(Emblica officinalis). Additional
components include Chavya (Piper
chaba), Vayavidang (Embelia
ribes), Pippal (Piper longum),
Kalimirch (Piper nigrum), Sonth
(Zingiber officinale), and Gaj Pipal
(Scindapsus officinalis). Flavor
enhancers and additional agents
include Choti Elaichi (Elettaria
cardamomum), Dalchini
(Cinnamomum verum), Tejpatra
(Cinnamomum tamala), while
detoxifying and digestive
components like Danti
(Baliospermum montanum), Nisoth
(Operculina turpethum), and
Banslochan (Bambusa arundinacea)
also play crucial roles. Minerals used
include Loh Bhasma and natural
resins like Guggul (Commiphora
wightii).
Dose
2 Tablets BD
Anupana
Lukewarm Water (Koshna Jala)
Duration
Adhobhakta (After Meal)
Table No. 5.: Day 2,3,4 and 5 – 04/09/24, 05/09/24,
06/09/24, 07/09/24.
Medications
Dose
Anupana
Duration
Sanjeevani
Vati
2
Tablets
BD
Lukewarm
Water
(Koshna
Jala)
Adhobhakta
(After
Meal)
URI Plus
2
Tablets
BD
Lukewarm
Water
(Koshna
Jala)
Adhobhakta
(After
Meal)
Chitrakadi
Vati
2
Tablets
BD
Lukewarm
Water
(Koshna
Jala)
Pragbhakta
(Before
Meal)
Renotivate
Syrup
20 ml
BD
Lukewarm
Water
(Koshna
Jala)
Adhobhakta
(After
Meal)
Chander Vati
2
Tablets
BD
Lukewarm
Water
(Koshna
Jala)
Adhobhakta
(After
Meal)
Mutravardhak
Vati
2
Tablets
BD
Lukewarm
Water
(Koshna
Jala)
Adhobhakta
(After
Meal)
The Patient was discharged on 07/09/24 and on
discharge patient was advised to take following
medication for 3 months
1. Renal Support syrup – 20ml BD after meal
with equal amount of lukewarm water
2. GFR Powder – ½ Tsp BD after meal with
Lukewarm water
3. Chander Vati – 2-tab BD after meal with
Lukewarm water
4. Asthiposhak Vati – 2-tab BD after meal
with Lukewarm water
5. Fe cap – 2 cap BD after meal with
Lukewarm water
6. DS Powder ½ Tsp HS after meal with
Lukewarm water (to stop if loose motion)
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
8
Follow-Up and Outcomes :
After 5 days admission and after the series of
Panchakarma Treatment and Ayurvedic Medicines
and a follow-up of 3 months the results that were
seen are-
Table No. 6 : Outcomes – Objective Parameters
Parameters
Pre-
Treatment
(03/09/24)
Post-
Treatment
(12/12/24)
Sr Electrolyte
Sr. Sodium
139.3 mEq/L
139.4
mEq/L
Sr. Potassium
5.83 mEq/L
5.69 mEq/L
Sr. Chloride
104.3 mEq/L
102.9
mEq/L
Complete Blood
Count
Hb
8.2 gm/dl
8.0 gm/dl
TLC
11200 /cumm
12500
/cumm
RBC
2.88
mill/cumm
2.43
mill/cumm
Platelet Count
3.63
Lac/cumm
2.10
Lac/cumm
Renal Function
Test
Blood Urea
176.38 mg/dl
114.27
mg/dl
Sr. Creatinine
11 mg/dl
7.17 mg/dl
Sr. Uric Acid
9.60 mg/dl
8.64 mg/dl
Urine
Routine/Microscpic
Urine Protein
Present +
Present +
Pus Cells
8-10 /HPF
1-2 /HPF
Albumin/Globulin
Ratio
0.81
1.23
The changes in the subjective parameters that was
observed are-
Table No. 7 :Outcomes – Subjective Parameters
Parameters
Pre-Treatment
Post-
Treatment
Pain Severity
(VAS)
[11]
Patient reported
severe pain,
rated at 7 on a
scale of 1-10
during episodes
of renal colic.
Complete
resolution of
pain, with a
pain rating of
1 on a scale of
1-10.
Modified Borg
Scale
(Shortness of
Breath)
[12]
6/10 (marked
breathlessness
after mild
exertion)
2/10 (marked
relief in
breathlessness
after mild
exertion)
Fatigue
Severity Scale
(FSS
)[13]
Average score
of 6/7 (severe
fatigue
impacting daily
function)
Average score
of 3/7 (mild
fatigue)
Itch Severity
Scale (ISS)
[14]
5/10 (moderate
itching
affecting sleep
and daily
activities)
2/10
(occasional
itching with
minimal
impact)
Kidney Disease
Quality of Life
(KDQOL)
[15]
Overall score
40%
(significant
impact of
kidney disease
on quality of
life)
Overall score
70%
(moderate
improvement
in quality of
life with some
persistent
challenges)
The changes in the DTPA were observed as
Image 1: Before Treatment
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
9
Image 1: Before Treatment
Image 2: After Treatment
Discussion :
Chronic Kidney Disease (CKD) represents a
significant challenge in modern medicine due to its
complex pathophysiology and the increasing
prevalence worldwide. As a multisystem disease,
CKD typically progresses silently over years, often
diagnosed in advanced stages when therapeutic
options are limited. Modern management strategies
for CKD focuses on addressing the primary risk
factors such as hypertension and diabetes, which
are pivotal in slowing disease progression.
Pharmacological treatments like ACE inhibitors or
ARBs are commonly prescribed to manage
hypertension and to reduce the progression of renal
damage
[16]
. Additionally, stringent control of blood
glucose levels in diabetes is essential to prevent
diabetic nephropathy, a leading cause of CKD
[17]
.
As the disease advances, treatment modalities may
include renal replacement therapies such as dialysis
or kidney transplantation, which, while life-
sustaining, come with significant lifestyle and
health burdens
[18]
. Despite advancements in
medical treatment and management strategies,
CKD remains a leading cause of morbidity and
mortality, underscoring the need for further
research into more effective interventions and the
potential for prevention strategies starting from
earlier life stages
[19]
.
The pathophysiology (Samprapti) of chronic
kidney disease (CKD) or Vrikka Roga in Ayurvedic
terminology, can be viewed through the lens of the
imbalance in the body's doshic energies, primarily
involving the vitiation of Vata, Kapha and Pitta
doshas. Apana Vata, which governs the lower part
of the body involved in elimination of wastes, plays
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
10
a significant role in the functioning of the kidneys.
According to Ayurveda, disturbance in Apana Vata
leads to impaired elimination and accumulation of
toxins (Ama) in the body, which in the context of
CKD disturbs the kidney’s ability to filter and
eliminate waste effectively.
The weakening of the Dhatus (tissues), particularly
Mamsa (muscle tissue) and Medas (fat tissue), due
to sustained doshic imbalance further exacerbates
the disruption of kidney functions. Additionally, the
build-up of Ama could lead to Srotorodha
(blockage of channels), which manifests as the
progressive symptoms of CKD including fatigue,
swelling and metabolic disturbances like electrolyte
imbalances.
Successful interruption of this pathogenesis
(Samprapti Vighatana) involves a multipronged
approach aimed at restoring the balance of the
doshas, enhancing digestive fire (Agni), clearing
the channels (Srotas) of accumulated toxins and
rejuvenating affected tissues. In the case presented,
several Panchakarma therapies were employed as
part of Panchakarma to address the root causes of
CKD. Matra Basti with Guduchyadi Ksheer Basti
was administered to soothe Vata and remove Ama
from the pelvis. Abhyangam with Ksheerbala Oil
and Avgaha Swedanam procedures were
implemented to improve circulation, facilitate the
removal of toxins and alleviate pain and
discomfort. Additionally, Shiropichu with
Dhanvantaram Oil was utilized to calm the system
and reduce stress, providing a holistic approach to
patient care.
Multiple studies in Ayurveda have explored
similar interventions for kidney diseases. A
demonstrated significant improvements in renal
function indicators among patients treated with a
comprehensive Ayurvedic protocol including herbs
like Punarnava and therapies similar to those
employed in this case report
[20]
. These findings,
with significant enhancements in both biochemical
and symptomatic profiles of patients with CKD
undergoing integrated Ayurvedic and conventional
treatment
[21]
. These studies reinforce the potential
for Ayurvedic interventions to effectively mitigate
the progression of CKD and improve quality of life,
by addressing both the symptoms and root causes
of the disease as described in its Samprapti.The
array of Ayurvedic medicines prescribed in the case
of Chronic Kidney Disease (CKD) encompasses
various formulations each targeted to support
different aspects of the patient's health. Sanjeevani
Vati is noted for its rejuvenative qualities,
enhancing systemic resilience and energy,
beneficial for tackling the fatigue associated with
CKD. URI Plus aims to support urinary function
with diuretic herbs that promote renal clearance and
helps to manage fluid retention. Chitrakadi Vati
enhances digestive efficiency, crucial for reducing
toxin buildup that could otherwise strain the
kidneys. Renotivate Syrup and herbs in similar
formulations are selected for their nephroprotective
properties, aimed at directly supporting kidney
function and health. Chander Vati assists in
metabolic regulation, potentially easing the burden
on the kidneys by improving the handling of
metabolic wastes. To stave off complications like
urinary tract infections, which are prevalent in
CKD due to compromised immunity and altered
urinary function, Mutravardhak Vati incorporates
diuretic components to enhance urine output, helps
to prevent fluid overload, a common issue in CKD
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
11
patients. Through a holistic approach, these
medications collectively address the complex
symptomatic landscape of CKD, emphasizing not
only direct renal support but also broader systemic
health enhancement in line with Ayurvedic
principles.
Need for Further research and Study :
The integration of Ayurvedic medicine into chronic
kidney disease (CKD) (Vrikka Roga) management
necessitates rigorous research to validate its
efficacy and safety. Well-designed clinical trials,
particularly randomized controlled trials, are crucial
to assess the therapeutic benefits and risks of
Ayurvedic treatments compared to conventional
therapies. Additionally, mechanistic studies are
needed to understand the pharmacodynamics of
ayurvedic remedies and their interactions with renal
pathology. Longitudinal and personalized treatment
studies can further elucidate the long-term impacts
and individual effectiveness of Ayurvedic
approaches. Interdisciplinary research combining
Ayurvedic principles with modern nephrology
could lead to innovative, integrative treatment
models, helping standardize and globalize
Ayurvedic treatments within the framework of
modern healthcare.
Conclusion :
This case report on the management of
chronic kidney disease (CKD) in a 24-year-old
male shows significant improvements post-
integration of Ayurvedic treatments with
conventional methods, as evident through
symptomatic, vital, and investigational outputs.
Symptomatic relief was substantial, with severe
pain, marked breathlessness, severe fatigue, and
moderate itching all considerably reduced. Vital
signs remained stable with normal pulse and blood
pressure throughout the treatment. Investigative
results also reflected positive changes; Blood urea
reduced from 176.38 mg/dl to 114.27 mg/dl, serum
creatinine decreased from 11 mg/dl to 7.17 mg/dl,
and both potassium and chloride levels showed
slight improvements. DTPA Scan findings also
shows significant improvement as global gfr
improved from 6.3 ml/min to 10.1 ml/min.These
findings suggest that an integrated approach to
CKD management can significantly enhance
patient outcomes, highlighting the need for further
research to validate and optimize these treatment
protocols.
References :
1. Levey AS, Eckardt K-U, Tsukamoto Y, et
al. Definition and classification of chronic
kidney disease: A position statement from
kidney disease: Improving Global
Outcomes (KDIGO). Kidney Int.
2005;67(6):2089-2100.
2. Thomas R, Kanso A, Sedor JR. Chronic
Kidney Disease and Its Complications. Prim
Care. 2008;35(2):329-344.
3. Kidney Disease: Improving Global
Outcomes (KDIGO) Acute Kidney Injury
Work Group. KDIGO Clinical Practice
Guideline for Acute Kidney Injury. Kidney
Int Suppl. 2012; 2:1-138.
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
12
4. Ruggenenti P, Cravedi P, Remuzzi G. The
RAAS in the pathogenesis and treatment of
diabetic nephropathy. Nat Rev Nephrology.
2010;6(6):319-330.
5. Sharma H, Chandola HM. Clinical
evaluation of the hepatoprotective effect of
Katuki (Picrorhiza kurroa) and Punarnava
(Boerhavia diffusa) in patients of acute viral
hepatitis. Int J Ayurveda Res.
2010;1(4):215-221.
6. Calabrese C, Gregory WL, Leo M, et al.
Effects of a standardized Bacopa monnieri
extract on cognitive performance, anxiety,
and depression in the elderly: a randomized,
double-blind, placebo-controlled trial. J
Altern Complement Med. 2008;14(6):707-
713.
7. Mishra A, Shukla S. An Ayurvedic
perspective on the management of chronic
kidney disease: A case report. J Ayurveda
Integr Med. 2014;5(3):181-185.
8. Singh AK, Farag YM, Mittal BV, et al.
Epidemiology and risk factors of chronic
kidney disease in India – results from the
SEEK (Screening and Early Evaluation of
Kidney Disease) study. BMC Nephrology.
2013; 14:114.
9. Acharya M, Chaudhary G, Singh SP, Singh
M, Richa. Clinical Evaluation of Chronic
Kidney Disease Management: Integrating
Lifestyle Modification and Ayurveda. Int J
AYUSH. 2024 Oct;2013(10):1152. doi:
10.22159/prl.ijayush.v2013i10.1152.
10. Charaka Saṃhitā, Sutrasthana, Chapter 27
Shloka 88. Edited by Vidyadhar Shukla
Acharya, Prof. Ravi Dutt Tripathi:
Chaukhambha Sanskrit Pratishthan Delhi.
11. Price DD, McGrath PA, Rafii A,
Buckingham B. The validation of visual
analogue scales as ratio scale measures for
chronic and experimental pain. Pain. 1983
Sep;17(1):45-56.
12. Borg GA. Psychophysical bases of
perceived exertion. Med Sci Sports Exerc.
1982;14(5):377-381.
13. Krupp LB, LaRocca NG, Muir-Nash J,
Steinberg AD. The fatigue severity scale.
Application to patients with multiple
sclerosis and systemic lupus erythematosus.
Arch Neurol. 1989 Oct;46(10):1121-3.
14. Reich A, Heisig M, Phan NQ, et al. Visual
Analogue Scale: evaluation of the
instrument for the assessment of pruritus.
Acta Derm Venereol. 2012;92(5):497-501.
15. Hays RD, Kallich JD, Mapes DL, Coons SJ,
Carter WB. Development of the Kidney
Disease Quality of Life (KDQOL)
instrument. Qual Life Res. 1994
Oct;3(5):329-38.
Issue : 04
INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]
Volume : 02
Copyright @ : - Dr.Gitika Chaudhary Inter. J.Digno. and Research IJDRMSID00045 |ISSN :2584-2757
13
16. Lewis EJ, Hunsicker LG, Clarke WR, et al.
Renoprotective effect of the angiotensin-
receptor antagonist irbesartan in patients
with nephropathy due to type 2 diabetes. N
Engl J Med. 2001;345(12):851-860.
17. Zoungas S, Arima H, Gerstein HC, et al.
Effects of intensive glucose control on
microvascular outcomes in patients with
type 2 diabetes: a meta-analysis of
individual participant data from randomised
controlled trials. Lancet Diabetes
Endocrinol. 2017;5(6):431-437.
18. Wolfe RA, Ashby VB, Milford EL, et al.
Comparison of mortality in all patients on
dialysis, patients on dialysis awaiting
transplantation, and recipients of a first
cadaveric transplant. N Engl J Med.
1999;341(23):1725-1730.
19. Coresh J, Selvin E, Stevens LA, et al.
Prevalence of chronic kidney disease in the
United States. JAMA. 2007;298(17):2038-
2047.
20. Mishra S. Therapeutic Potentials of Herbs
and Plant Extracts Against Acute on
Chronic Kidney Diseases: A
Review. Journal of Ayurveda and
Integrative Medicine 2019; 10(1): 55–63.
21. Gupta A. Clinical Documentation of Kidney
Regeneration with Ayurvedic Therapy in
Patients with Chronic Kidney Disease.Ayu
(An international quarterly journal of
sresearch in Ayurveda) 2018; 39(4): 257-
263.
ISSN: 2584-2757
DOI : 1 0 . 5 2 8 1 / z e n o d o . 1 6 0 29464
Dr. Gitika Chaudhary Inter. J.Digno. and Research
This work is licensed under Creative
Commons Attribution 4.0 License
Submission Link : http://www.ijdrindia.com
Benefits of Publishing with us
Fast peer review process
Global archiving of the articles
Unrestricted open online access
Author retains copyright
Unique DOI for all articles
https://ijdrindia.com
